VYNE Therapeutics

VYNE Therapeutics is a late-stage biopharmaceutical company dedicated to the development and commercialization of serlopitant for the treatment of pruritus associated with dermatological conditions such as atopic dermatitis, psoriasis, and prurigo nodularis.